Search

Mehdi Paborji

from Los Gatos, CA
Get Report
Also known as:
Mehdei Paborji, Mehdi K Paborji, Mehdi S Paborji, M Paborji
Phone and address:
300 Santa Rosa Dr, Los Gatos, CA 95032
(408) 390-1614
Related to:
Danoush Paborji, 38Shahrzad Paborji, 64
Connected to:
Jiri Paboucek, 45Adrian Pabros, 35Amanda M Pabst, 39Corrie L Pabst, 48Ellen F Pabst, 85Eric L Pabst, 58Geoff Pabst, 34Helen M Pabst, 90Jennie N Pabst, 32Julie M Pabst, 57

Mehdi Paborji Phones & Addresses

  • 300 Santa Rosa Dr, Los Gatos, CA 95032 (408) 390-1614
  • Liverpool, NY
  • 10351 Byrne Ave, Cupertino, CA 95014 (408) 255-6565
  • Irvine, CA
  • Belle Mead, NJ
  • Foster City, CA
  • Baldwinsville, NY
  • Trenton, NJ
  • Colorado Springs, CO
  • 10351 Byrne Ave, Cupertino, CA 95014 (408) 242-2915

Work

Position: Construction and Extraction Occupations

Emails

m***[email protected]

Resumes

Resumes

Mehdi Paborji Photo 1

Founder

View page
Location:
27662 Aliso Creek Rd, Aliso Viejo, CA 92656
Industry:
Pharmaceuticals
Work:
Lucidus Pharma
Founder
Biotie Therapies Corp. Jan 1, 2014 - Aug 2017
Chief Operating Officer and Ssf Site Head
Theravida 2005 - Jan 2014
Founder and Chief Operating Officer
Korea Health Industry Development Institute 2005 - Jan 2014
Global Pharma Key Opinion Leader
Theravance Biopharma Us, Inc. 2001 - 2004
Senior Director
Education:
The University of Kansas 1980 - 1986
The University of Kansas 1985
Doctorates, Doctor of Philosophy, Biology, Organic Chemistry
Skills:
Biotechnology
Pharmaceutical Industry
Technology Transfer
Drug Discovery
Formulation
Pharmaceutics
Clinical Research
Clinical Development
Commercialization
Life Sciences
Drug Development
R&D
Biopharmaceuticals
Lifesciences
Product Development
Fda
Ind
Gmp
Oncology
Clinical Trials
Patents
Mehdi Paborji Photo 2

Mehdi Paborji

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mehdi Paborji
Theravida, LLC
Testing Lab
10 Vanderbilt, Irvine, CA 92618

Publications

Us Patents

Therapy For The Treatment Of Disease

View page
US Patent:
7666894, Feb 23, 2010
Filed:
Sep 8, 2009
Appl. No.:
12/555806
Inventors:
Mehdi Paborji - Cupertino CA, US
Assignee:
TheraVida, Inc. - San Mateo CA
International Classification:
A61K 31/4178
A61K 31/216
US Classification:
514397, 514534
Abstract:
Disclosed herein are pharmaceutical compositions comprising oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.

Compositions For The Treatment Of Overactive Bladder

View page
US Patent:
7678821, Mar 16, 2010
Filed:
Aug 28, 2006
Appl. No.:
11/467760
Inventors:
Mehdi Paborji - Cupertino CA, US
Assignee:
TheraVida, Inc. - San Mateo CA
International Classification:
A61K 31/4178
A61K 31/137
US Classification:
514397, 514648
Abstract:
Disclosed herein are pharmaceutical compositions comprising combinations of tolterodine, an antimuscarinic agent, and pilocarpine, a compound that causes stimulation of salivary glands. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient said pharmaceutical composition.

Therapy For The Treatment Of Disease

View page
US Patent:
7781472, Aug 24, 2010
Filed:
Feb 22, 2010
Appl. No.:
12/710310
Inventors:
Mehdi Paborji - Cupertino CA, US
Assignee:
TheraVida, Inc. - San Mateo CA
International Classification:
A61K 31/4178
A61K 31/216
US Classification:
514397, 514534
Abstract:
Disclosed herein are pharmaceutical compositions comprising oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.

Compositions And Methods For The Treatment Of Overactive Bladder

View page
US Patent:
8470864, Jun 25, 2013
Filed:
Feb 22, 2010
Appl. No.:
12/710301
Inventors:
Mehdi Paborji - Cupertino CA, US
Assignee:
Theravida, Inc. - Mountain View CA
International Classification:
A61K 31/00
A61K 31/137
A61K 31/216
A61K 31/46
US Classification:
514397, 514534, 514648
Abstract:
Disclosed herein are pharmaceutical compositions comprising oxybutynin or tolterodine, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.

Crystalline Beta2 Adrenergic Receptor Agonist

View page
US Patent:
20050075271, Apr 7, 2005
Filed:
Jul 25, 2003
Appl. No.:
10/627555
Inventors:
Martin Linsell - San Francisco CA, US
John Jacobsen - San Mateo CA, US
Davar Khossravi - San Mateo CA, US
Mehdi Paborji - Cupertino CA, US
Weijiang Zhang - Cupertino CA, US
International Classification:
A61K031/00
US Classification:
514001000
Abstract:
The invention provides a crystalline salt form of a novel βadrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with βadrenergic receptor activity, and processes useful for preparing such a crystalline compound.

Therapy For The Treatment Of Disease

View page
US Patent:
20090275629, Nov 5, 2009
Filed:
Jul 15, 2009
Appl. No.:
12/503432
Inventors:
Mehdi Paborji - Cupertino CA, US
Assignee:
THERAVIDA, INC. - San Mateo CA
International Classification:
A61K 31/4178
A61P 25/00
US Classification:
514397
Abstract:
Disclosed herein are pharmaceutical compositions comprising various combinations of an antimuscarinic or an anticholinergic agent, a compound that causes stimulation of salivary glands, and a compound that relieves constipation. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.

Pharmaceutical Formulations For The Treatment Of Overactive Bladder

View page
US Patent:
20110244051, Oct 6, 2011
Filed:
Apr 1, 2011
Appl. No.:
13/078881
Inventors:
Mehdi PABORJI - San Mateo CA, US
Roger S. FLUGEL - San Mateo CA, US
Assignee:
THERAVIDA, INC. - San Mateo CA
International Classification:
A61K 9/16
A61K 31/4178
A61K 31/439
A61K 31/137
A61K 31/222
A61K 31/216
A61K 31/4725
A61K 31/4025
A61K 31/403
A61K 31/4174
A61K 31/445
A61K 31/215
A61P 13/10
US Classification:
424495, 424490, 514397, 514278, 424494, 424493, 424497, 424496, 424498, 514648, 514546, 514534, 514305, 514422, 514409, 514399, 514327, 514529
Abstract:
Disclosed herein are pharmaceutical compositions comprising a plurality of first beads each comprising: a core; a first layer comprising pilocarpine or a pharmaceutically acceptable salt thereof; and a second layer comprising a first polymer. Also disclosed are pharmaceutical compositions comprising a plurality of second beads each comprising: a core; and a first layer comprising tolterodine or a pharmaceutically acceptable salt thereof. Further disclosed are pharmaceutical formulations comprising: a) a plurality of the first beads; b) a plurality of the second beads; or c) a plurality of the first beads and a plurality of the second beads.

Methods Of Improving Quality Of Sleep

View page
US Patent:
20110245294, Oct 6, 2011
Filed:
Apr 1, 2011
Appl. No.:
13/078826
Inventors:
Mehdi PABORJI - San Mateo CA, US
Roger S. FLUGEL - San Mateo CA, US
Assignee:
THERAVIDA, INC. - San Mateo CA
International Classification:
A61K 31/439
A61K 31/4178
A61K 31/24
A61P 13/10
US Classification:
514305, 514397, 514534
Abstract:
Disclosed herein are methods of treating a patient suffering from overactive bladder (OAB) comprising administering to the patient a combination of antimuscarinic or anticholinergic agent and muscarinic agonist for the treatment of poor quality of sleep in the OAB patient.
Control profile
Mehdi Paborji from Los Gatos, CA Get Report